Actualités 2014: Le point de vue du comité de rédaction du Bulletin du Cancer

Christophe Massard; Jacques Olivier Bay; Thierry André; Jean Yves Blay; Anthony Goncalves; Daniel Orbach; Marie Wislez; Juliette Thariat; Nicolas Magné; Stéphane Vignot

doi:10.1016/j.bulcan.2014.11.002

Actualités 2014: Le point de vue du comité de rédaction du Bulletin du Cancer

Christophe Massard, Jacques Olivier Bay, Thierry André, Jean Yves Blay, Anthony Goncalves, Daniel Orbach, Marie Wislez, Juliette Thariat, Nicolas Magné, Stéphane Vignot

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

1 Citation (Scopus)

Résumé

Results of many clinical trials are presented each year during the American Society of Clinical Oncology meeting, ESMO meeting and other international major meetings. This article is proposed by the editorial board of the Bulletin du Cancer as a synthesis of new important results in clinical trials concerning cancer patients treated for hematology cancer or solid tumors. The goal of this review is to highlight the main results that may have an immediate impact on our clinical practices for physicians and patients.

Titre traduit de la contribution	Major advances in oncology in 2014: The editorial board of the Bulletin du Cancer point of view
langue originale	Français
Pages (de - à)	83-91
Nombre de pages	9
journal	Bulletin du Cancer
Volume	102
Numéro de publication	1
Les DOIs	https://doi.org/10.1016/j.bulcan.2014.11.002
état	Publié - 1 janv. 2015

mots-clés

ASCO 2014
Cancer
ESMO/ECCO 2014

Accès au document

10.1016/j.bulcan.2014.11.002

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{51bd1a3b678c4ff6b95be84266b32e46,

title = "Actualit{\'e}s 2014: Le point de vue du comit{\'e} de r{\'e}daction du Bulletin du Cancer",

abstract = "Results of many clinical trials are presented each year during the American Society of Clinical Oncology meeting, ESMO meeting and other international major meetings. This article is proposed by the editorial board of the Bulletin du Cancer as a synthesis of new important results in clinical trials concerning cancer patients treated for hematology cancer or solid tumors. The goal of this review is to highlight the main results that may have an immediate impact on our clinical practices for physicians and patients.",

keywords = "ASCO 2014, Cancer, ESMO/ECCO 2014",

author = "Christophe Massard and Bay, {Jacques Olivier} and Thierry Andr{\'e} and Blay, {Jean Yves} and Anthony Goncalves and Daniel Orbach and Marie Wislez and Juliette Thariat and Nicolas Magn{\'e} and St{\'e}phane Vignot",

note = "Publisher Copyright: {\textcopyright} 2014 Soci{\'e}t{\'e} Fran{\c c}aise du Cancer. Publi{\'e} par Elsevier Masson SAS. Tous droits r{\'e}serv{\'e}s.",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/j.bulcan.2014.11.002",

language = "Fran{\c c}ais",

volume = "102",

pages = "83--91",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "1",

}

TY - JOUR

T1 - Actualités 2014

T2 - Le point de vue du comité de rédaction du Bulletin du Cancer

AU - Massard, Christophe

AU - Bay, Jacques Olivier

AU - André, Thierry

AU - Blay, Jean Yves

AU - Goncalves, Anthony

AU - Orbach, Daniel

AU - Wislez, Marie

AU - Thariat, Juliette

AU - Magné, Nicolas

AU - Vignot, Stéphane

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Results of many clinical trials are presented each year during the American Society of Clinical Oncology meeting, ESMO meeting and other international major meetings. This article is proposed by the editorial board of the Bulletin du Cancer as a synthesis of new important results in clinical trials concerning cancer patients treated for hematology cancer or solid tumors. The goal of this review is to highlight the main results that may have an immediate impact on our clinical practices for physicians and patients.

AB - Results of many clinical trials are presented each year during the American Society of Clinical Oncology meeting, ESMO meeting and other international major meetings. This article is proposed by the editorial board of the Bulletin du Cancer as a synthesis of new important results in clinical trials concerning cancer patients treated for hematology cancer or solid tumors. The goal of this review is to highlight the main results that may have an immediate impact on our clinical practices for physicians and patients.

KW - ASCO 2014

KW - Cancer

KW - ESMO/ECCO 2014

UR - http://www.scopus.com/inward/record.url?scp=84965087856&partnerID=8YFLogxK

U2 - 10.1016/j.bulcan.2014.11.002

DO - 10.1016/j.bulcan.2014.11.002

M3 - Article 'review'

C2 - 25609486

AN - SCOPUS:84965087856

SN - 0007-4551

VL - 102

SP - 83

EP - 91

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - 1

ER -